Target intelligence / Profile preview

Mucous cell and serous cell of airway epithelium

Molecular classification
Other (cell type)
01

Overview

Mucous cells (including goblet cells in the surface epithelium and mucous cells in submucosal glands) secrete high molecular weight mucins forming the mucus layer that traps particulates and pathogens. Serous cells, prevalent in submucosal glands, secrete watery fluids rich in proteins such as lysozyme, lactoferrin, and antimicrobial peptides, contributing to innate defense and maintaining mucus properties. Together, these cells are critical for mucociliary clearance and host defense in the airway. Altered function or number of these cells is central to the pathogenesis of airway diseases such as asthma, COPD, and chronic bronchitis. Key point: "Mucous and serous cells in airway epithelium" does not refer to a singular molecule or druggable target but to two epithelial cell types with important defensive and secretory roles. If you are seeking drug targets, focus would shift to specific molecular components such as mucin genes (e.g., MUC5AC) or regulatory receptors on these cells.

Other names
Airway mucous cellAirway serous cellSubmucosal gland mucous cellSubmucosal gland serous cellGoblet cell (for mucous-producing cells within the surface epithelium)
02

Mechanism of action

Modulation of mucus production or secretion (indirect, via receptor or signaling pathway modulation rather than direct targeting of cell types); Anti-inflammatory effects reducing hypersecretion

03

Biological functions

Mucus secretionBarrier functionInnate immune defenseAntimicrobial secretion (serous cells)Mucociliary clearance support
04

Disease associations

Inflammation (e.g., asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis)InfectionOther (e.g., cystic fibrosis, airway hyperresponsiveness)
05

Safety considerations

Excessive inhibition or stimulation of mucus/serous secretion can impair airway defense, mucociliary clearance, and increase infection risk
06

Interacting drugs

Drugs do not interact directly with these cell types as discrete targets; rather, drugs may modulate mucus production or secretion as a tissue-level effect.

4 more in the full profile.

07

Biomarkers

Mucin proteins: MUC5AC (goblet cells)MUC5B (mucous cells)Lysozyme, lactoferrin, lactoperoxidase (serous cell secretions)

Beyond the preview

Go deeper on Mucous cell and serous cell of airway epithelium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucous cell and serous cell of airway epithelium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call